The Oracle of Omaha Goes Value Shopping in the Value Pharmaceutical Bin with Teva (TEVA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teva (TEVA) volatility increases after Berkshire Hathaway (BRK.A) disclosed a stake in the company
February 15, 2018 10:14 AM ESTTeva Pharma (NYSE: TEVA) February call option implied volatility is at 78, March is at 47; compared to its 52-week range of 24 to 75 after Berkshire Hathaway (BRK.A) disclosed a stake in the company.
... MoreActive options: CSCO TEVA ABX WM FB TEVA NFLX
February 15, 2018 10:09 AM ESTActive options: CSCO TEVA ABX WM FB TEVA NFLX
... MoreTeva Pharma (TEVA) call put ratio 1.5 calls to 1 put
February 15, 2018 9:43 AM ESTTeva Pharma (NYSE: TEVA) call put ratio 1.5 calls to 1 put
Popular active stocks: APC TEVA PEP
February 15, 2018 9:41 AM ESTPopular active stocks: APC TEVA PEP
... MorePre-Open Movers 02/15: (AMAG) (SEDG) (TEVA) Higher; (CDMO) (THS) (NTAP) Lower (more...)
February 15, 2018 9:23 AM ESTToday's Pre-Open Movers
Avid Bioservices, Inc. (NASDAQ: CDMO) 27.1% LOWER; announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $2.25 per share
Citi Remains Bullish on Teva Pharma (TEVA) Amid Buffett Stake
February 15, 2018 7:18 AM ESTCiti reiterated a Buy rating and $24.00 price target on Teva Pharma (NYSE: TEVA) following the company's 13-F filing. Berkshire Hathaway reported a new stake of 18.9mn shares in TEVA, representing a total investment of ~$360mn at current levels.
Analyst Liav Abraham... More
Berkshire buys Teva, feels IBM blues as Apple becomes top investment
February 14, 2018 4:50 PM ESTBy Jonathan Stempel
(Reuters) - Warren Buffett's Berkshire Hathaway Inc on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and said it bought more shares of Apple Inc (NASDAQ: AAPL), which surpassed Wells Fargo & Co (NYSE: WFC) as its largest common stock investment.
Berkshire also nearly completed its yearlong exit from International Business Machines Corp (NYSE: IBM), selling more than 94 percent of what was left from an investment... More
Buffett's Berkshire Hathaway Enters New Stake in Teva (TEVA), Adds to Apple (AAPL), BofA (BAC) (more...) - 13F
February 14, 2018 4:13 PM ESTWarren Buffett's Berkshire Hathaway relased its 13F for the quarter ended Dec. 31, 2017. Below is a summary:
New Stakes
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) new 18,875,721 share position
Raised Stakes
Apple Inc. (NASDAQ: AAPL) raised from 134,092,782 shares to 165,333,962 shares
Bank of New York (NYSE: BK) raised from 50,229,588 shares to 60,818,783 shares
The Liberty SiriusXM Group (NASDAQ: LSXMA) raised from 14,860,360 shares to 31,090,985 shares
Monsanto Company (NYSE: MON) raised from 8,873,469 shares to 11,708,747... More
Buffett's Berkshire enters Teva Pharma (NYSE: TEVA)
February 14, 2018 4:09 PM ESTBuffett's Berkshire enters Teva Pharma (NYSE: TEVA)
